Public Health Campaigns for Lead Poisoning

BG
Overseen ByBrian Goldstein, MD MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: International Health Strategies LLC
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This clinical trial aims to evaluate the effectiveness of targeted public health campaigns in reducing lead exposure among adults living in urban communities with known environmental lead hazards. Lead exposure remains a significant public health concern, particularly in older urban neighborhoods with aging infrastructure and legacy contamination. Despite existing regulations and remediation efforts, many communities continue to experience elevated blood lead levels, especially among vulnerable populations.

The study will compare the impact of an intensive, multi-modal public health campaign-featuring community workshops, educational materials, and home intervention resources-against standard municipal information dissemination. By assessing changes in blood lead levels and lead-related knowledge, attitudes, and behaviors over a 12-month period, the trial seeks to determine whether enhanced public health outreach can more effectively reduce lead exposure and promote safer practices. The findings will inform future strategies for community-based environmental health interventions.

Who Is on the Research Team?

BG

Brian Goldstein, MD MPH

Principal Investigator

International Health Strategies LLC

Are You a Good Fit for This Trial?

This trial is for adults aged 18-75 living in certain urban neighborhoods with known lead risks. Participants must be willing to join the study, allow home visits and blood tests, and understand what the study involves.

Inclusion Criteria

Resident of selected urban neighborhoods with documented environmental lead risk
My household has at least one adult aged 18-75 willing to join the study.
Willing to provide informed consent
See 2 more

Exclusion Criteria

Household member with a known diagnosis of severe anemia or bleeding disorder
I am currently pregnant.
Planning to relocate from the area within the next 12 months
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive either an intensive public health campaign or standard information dissemination

12 months
Multiple home visits and community workshops

Follow-up

Participants are monitored for changes in blood lead levels and lead-related knowledge, attitudes, and behaviors

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Intensive Public Health Campaign
  • Standard Information Dissemination

Trial Overview

The study compares an intensive public health campaign (with workshops, educational materials, and home help) to standard city information sharing. It measures if these approaches lower blood lead levels and improve knowledge over a year.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Intensive Public Health CampaignExperimental Treatment1 Intervention
Group II: Standard Information DisseminationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

International Health Strategies LLC

Lead Sponsor